Induction of patients with moderately severe methadone dependence onto buprenorphine

Addiction Biology

Volumn 10, Issue 2, 2005, Pages 149-155

  Glasper, A ^c   Reed, L J ^a,b   De Wet, C J ^a   Gossop, M ^a,b   Bearn, Jennifer ^a,b  

^a BETHLEM ROYAL HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; LOFEXIDINE; METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE ACCESS; HUMAN; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; RATING SCALE;

ADULT; BUPRENORPHINE; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHADONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 22144488082     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210500123126     Document Type: Article

References (30)

1. Barnett PG, Rodgers JH, Bloch DA (2001) A meta-analysis comparing buprenorphine to methadone for treatment of opioid dependence. Addiction 96:683-690.
2. Bearn J, Gossop M, Strang J (1996) Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opioid withdrawal. Drug Alcohol Depend 43:87-91.
3. Bell G, Cohen J, Cremona A (1990) How willing are general practitioners to manage narcotic misuse? Health Trends 2:56-57.
4. Breen CL, Harris SJ, Lintzeris N, Mattick RP, Hawken L, Bell J, Ritter AJ, Lenne M, Mendoza E (2003) Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend 71:49-55.
5. Department of Health (1999) Drug Misuse and Dependence. Guidelines on Clinical Management http://www.doh.gov.uk/ drugs/pdfs/dmfull.pdf.
6. Dum JE, Herz A (1981) In vivo receptor binding of the opioid partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions. Br J Pharmacol 74:627-633.
7. Emrich HM, Gunther R and Dose M (1983) Current perspectives in the pharmacopsychiatry of depression and mania. Neuropharmacology 22:385-388.
8. Gossop M (1990) The development of a short opioid withdrawal scale (SOWS). Addict Behav 15:487-490.
9. Gossop M, Marsden J, Stewart D, Treacy S (2001) Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 62:255-264.
10. Gowing L, Farrell M, Ali R, White J (2003) Alpha2 adrenergic agonists for the management of opioid withdrawal (Cochrane Review). In: The Cochrane Library, Issue 4.
11. Groves P, Heuston J, Durand MA, Albery I, Gossop M, Strang J (1996) The identification and management of substance misuse problems by general practitioners. J Mental Health 5:183-193.
12. Johnson R, Strain E, Amass L (2003) Buprenorphine: how to use it right. Drug Alcohol Depend 70:59-77.
13. Law FD, Bailey JE, Allen DS, Melichar JK, Myles JS, Mitcheson MC, Lewis JW, Nutt DJ (1997) The feasibility of abrupt methadone-buprenorphine transfer in British opioid addicts in an outpatient setting. Addict Biol 2:191-200.
14. Lawrence J, Cheskin LJ, Fudala PJ, Johnson RE (1994) A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug Alcohol Depend 36:115-121.
15. Leander JD (1987) Buprenorphine has potent kappa opioid receptor antagonist activity. Neuropharmacology 26:1445-1447.
16. Levin FR, Fischman MW, Connerney I, Foltin RW (1996) A protocol to switch high-dose, methadone maintained patients to buprenorphine. Am J Addict 6:105-116.
17. Lin SK, Strang J, Su LW, Tsai CJ, Hu WH (1997) Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend 48:127-133.
18. Marsden J, Gossop M, Stewart D (1998) The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 93:1857-1868.
19. Mattick RP, Kimber J, Breen C, Davoli M (2003) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). In: The Cochrane Library, Issue 1.
20. Milby JB, Gurwitch RH, Wiebe DJ (1986) Prevalence and diagnostic reliability of methadone maintenance fear. Am J Psychiatry 143:739-743.
21. Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J (2001) Injecting misuse of buprenorphine among French drug users. Addiction 96:267-272.
22. Petitjean S, Stohler R, Deglon JJ, Livoti S, Waldvogel D, Uehlinger C, Ladewig D (2001) Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend 62:97-104.
23. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opioid withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
24. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1996) Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacology 16:58-67.
25. Thirion X, Lapierre V, Micallef J, Ronflé E, Masut A, Pradela V, Coudert C, Mabriez J, Sanmarco J (2002) Buprenorphine prescription by general practitioners in a French region. Drug Alcohol Depend 65:197-204.
26. Vignau J, Duhamel A, Catteau J, Legal G, Huynh PA, Grailles I, Beauvillain J, Petit P, Beauvillain P, Parquet P (2001) Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opioid-addicted patients? J Subst Abuse Treat 21:135-144.
27. Walsh SL, Preston KL, Bigelow GE, Stitzer ML (1995) Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 274:361-372.
28. Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML (1995) Effects of buprenorphine in methadone-maintained patients. Psychopharmacology 119:268-276.
29. Ward J, Hall W, Mattick RP (1999) Role of maintenance treatment in opioid dependence. Lancet 353:221-226.
30. West SL, O'Neal KK, Graham CW (2000) A meta-analysis comparing the effectiveness of buprenorphine and methadone. J Subst Abuse 12:405-414.